We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Urgent public health message: UKHSA has been notified about an outbreak of food botulism in France involving a small number of British nationals.
Information on cryptosporidium including sources and routes of transmission, symptoms, and general hygiene advice to minimise the spread.
Find out about the long-term effects some people can have after having COVID-19.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
The characteristics, diagnosis, management, surveillance and epidemiology of Shiga toxin-producing Escherichia coli (STEC).
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
The epidemiology, symptoms, diagnosis and management of Andes hantavirus infection.
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
Advice and guidance on the health needs of migrant patients for healthcare practitioners
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Guidance and support on coronavirus (COVID-19) in Scotland.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Information on COVID-19, including guidance on the assessment and management of suspected UK cases.
Applications, changes and cancellations for consideration under the UK geographical indications (GI) schemes, how to object and appeal against decisions.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.